1Department of Obstetrics and Gynecology, Biostatistics and Epidemiology, Family and Preventive Medicine University of Oklahoma Health Sciences Center, Oklahoma City, OK
2Statistical Research Associate, Fred Hutchinson Cancer Research Center, Seattle, WA
3Department of Medicine, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, CA
4Department of Family Medicine, University of California San Diego School of Medicine, La Jolla, CA
5The North American Menopause Society Emeritus, Cleveland, OH
6Barbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA
7Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
8Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA.
Address correspondence to: Robert A. Wild, MD, MPH, PhD, Department of Obstetrics and Gynecology, Biostatistics and Epidemiology, Family and Preventive Medicine University of Oklahoma Health Sciences Center, AAT 2466, 800 SLYoung Blvd, Oklahoma City, OK 73104. E-mail: [email protected]
Received 12 January, 2021
Revised 18 May, 2021
Accepted 18 May, 2021
Funding/support: whi.org NIH contracts HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C.
Financial disclosure/conflicts of interest: R.A.W. has received funding from Esperion, Amgen, NICHD, and Quest Diagnostics. R.A.W. also serves on the American Board of Clinical Lipidology and the Board of the National Lipid Association (NLA Foundation). The other authors have nothing to disclose.
Supplemental digital content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's Website (www.menopause.org).
